Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWoodbois Regulatory News (WBI)

  • This share is currently suspended. It was suspended at a price of 0.03
  • There is currently no data for WBI

Nominated Adviser Status

1 Nov 2018 11:43

RNS Number : 0498G
Obtala Limited
01 November 2018
 

 

1 November 2018

Obtala Limited

("Obtala" or the "Company")

(AIM: OBT)

Nominated Adviser Status

 

The directors of Obtala are aware of the proposed merger of its current nominated adviser, Northland Capital Partners ("Northland") with SP Angel Corporate Finance LLP. The directors have also been informed that Northland has voluntarily agreed to relinquish its nominated adviser status and will be removed from the register of nominated advisers with effect from 7am on 1 February 2019.

In accordance with AIM Rule 1, if the Company fails to appoint a new nominated adviser by 1 February 2019 the Exchange will suspend trading in the Company's AIM Securities. If the Company has failed to appoint a replacement nominated adviser by 4 March 2019 the admission of its AIM Securities will be cancelled.

The Company's board is in talks with several nominated advisors and are confident that a suitable replacement will be appointed by 1 February 2019.

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 ("MAR").

 

 

Obtala Limited

Miles Pelham - ChairmanPaul Dolan - CEO

Martin Collins - Deputy Chairman

www.obtala.com

 

+44 (0)20 7099 1940

Northland Capital Partners Ltd (Nomad and Broker)

David Hignell/ Dugald J. Carlean/ Domile Andruskeviciute

 

+44 (0)20 3861 6625

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
APPUGGBWGUPRGGG
Date   Source Headline
27th Jun 20247:00 amRNSAppointment of Independent Non-Executive Director
24th Jun 20247:00 amRNS$5m Trade Finance Facility Completed
12th Jun 20247:00 amRNSBoard Changes & Trading Update
10th Jun 20247:00 amRNSUpdate on Publication of Financial Statements
23rd May 20241:43 pmRNSHolding(s) in Company
13th Mar 20247:00 amRNSMozambique Operations to be Divested
8th Feb 20247:05 amRNS£2.0m Exercise of Warrants to scale-up production
8th Feb 20247:00 amRNS$5m Trade Finance, Gabon Progress & 2024 Outlook
12th Jan 20247:00 amRNSIssuance of Shares and Warrants
5th Jan 20247:00 amRNSCEO Departure Commences Restructuring
29th Dec 202312:27 pmRNSResults of Annual General Meeting
29th Dec 20237:00 amRNSBoard Change, Strategic Initiatives & Joint Broker
4th Dec 20237:00 amRNSDirectorate Change
22nd Nov 20237:00 amRNSNotice of Annual General Meeting
29th Sep 20237:00 amRNSHalf Year Results
30th Aug 20239:05 amRNSStatement re Share Price Movement
29th Jun 20231:30 pmRNSDirector/PDMR Shareholding
28th Jun 20237:00 amRNSSubscription, Debt Refinancing & Issue of Warrants
16th Jun 202312:00 pmRNSResults of General Meeting
9th Jun 20237:00 amRNSAudited results for FY 2022
6th Jun 20237:00 amRNSDebt Repayment Terms and Corporate Update
30th May 20237:00 amRNSNotice of General Meeting and Posting of Circular
19th Apr 202311:45 amRNSTR-1
19th Apr 20237:14 amRNSFacility with Sydbank A/S ("Sydbank")
11th Apr 20237:01 amRNSQ1 2023 Update
11th Apr 20237:00 amRNSConditional Award of Afforestation Project
13th Mar 20237:00 amRNSPlacing of £3 million
10th Mar 20231:00 pmRNSTR-1
10th Mar 202312:41 pmRNSResponse to market speculation
2nd Mar 20234:35 pmRNSPrice Monitoring Extension
1st Mar 202310:40 amRNSTR-1
24th Feb 202311:15 amRNSTR-1
31st Jan 20231:45 pmRNSTR-1
12th Jan 20237:00 amRNSQ4 2022 update
5th Dec 20225:30 pmRNSTR-1
11th Nov 20227:00 amRNSConversion of 55 million Non-Voting Shares
1st Nov 20228:15 amRNSTR-1
27th Oct 20225:15 pmRNSConversion of 60 million Non-Voting Shares
21st Oct 20227:00 amRNSTR-1
17th Oct 20227:00 amRNSQ3 2022 Upate an Boar change
17th Oct 20227:00 amRNSQ3 2022 Update and Board change
26th Sep 20224:15 pmRNSTR-1
26th Sep 20227:00 amRNSConversion of 60 million Non-Voting Shares
17th Aug 20227:00 amRNSEighth Ranking in SPOTT Transparency Assessment
10th Aug 20229:00 amRNSExercise of Options
4th Aug 20227:00 amRNSHalf Year Results
11th Jul 20227:00 amRNSQ2 2022 update
27th Jun 20227:00 amRNSConversion of 65 million Non-Voting Shares
16th Jun 20227:00 amRNSConversion of $243,591 of Convertible Bonds
14th Jun 20227:00 amRNSConversion of $50,000 of Convertible Bonds

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.